Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
1,2-naphthoquinone + NADPH
1,2-naphthoquinol + NADP+
1,2-naphthoquinone + NADPH + H+
1,2-naphthosemiquinone + NADP+
-
production of semiquinone by univalent catalysts is detectable by the reduction of ferricytochrome c by the semiquinone to ferrocytochrome c
-
-
?
1,2-naphthoquinone + NADPH + H+
? + NADP+
-
the activity with 9,10-phenanthrenequinone and with 1,2-naphthoquinone is equal
-
-
?
1,4-benzoquinone + NADPH
1,4-benzoquinol + NADP+
1,4-benzoquinone + NADPH + H+
1,4-benzosemiquinone + NADP+
-
production of semiquinone by univalent catalysts is detectable by the reduction of ferricytochrome c by the semiquinone to ferrocytochrome c
-
-
?
1,4-naphthoquinone + NADPH
1,4-naphthoquinol + NADP+
1,4-naphthoquinone + NADPH + H+
1,4-naphthosemiquinone + NADP+
-
production of semiquinone by univalent catalysts is detectable by the reduction of ferricytochrome c by the semiquinone to ferrocytochrome c
-
-
?
2 1,2-naphthoquinone + NADPH + H+
2 1,2-naphthosemiquinone + NADP+
-
production of semiquinone by univalent catalysts is detectable by the reduction of ferricytochrome c by the semiquinone to ferrocytochrome c
-
-
?
2 1,2-naphthoquinone + NADPH + H+
? + NADP+
-
the activity with 9,10-phenanthrenequinone and with 1,2-naphthoquinone is equal
-
-
?
2 1,4-benzoquinone + NADPH + H+
2 1,4-benzosemiquinone + NADP+
-
production of semiquinone by univalent catalysts is detectable by the reduction of ferricytochrome c by the semiquinone to ferrocytochrome c
-
-
?
2 1,4-benzoquinone + NADPH + H+
? + NADP+
-
weak activity
-
-
?
2 1,4-naphthosemiquinone + NADPH + H+
2 1,4-naphthosemiquinone + NADP+
-
production of semiquinone by univalent catalysts is detectable by the reduction of ferricytochrome c by the semiquinone to ferrocytochrome c
-
-
?
2 5-hydroxy-1,4-naphthoquinone + NADPH + H+
2 5-hydroxy-1,4-naphthosemiquinone + NADP+
-
i.e. juglone. Production of semiquinone by univalent catalysts is detectable by the reduction of ferricytochrome c by the semiquinone to ferrocytochrome c
-
-
?
2 5-hydroxy-2-methyl-1,4-naphthoquinone + NADPH + H+
5-hydroxy-2-methyl-1,4-naphthoquinone + NADP+
-
i.e. plumbagin. Production of semiquinone by univalent catalysts is detectable by the reduction of ferricytochrome c by the semiquinone to ferrocytochrome c
-
-
?
2 9,10-phenanthrenequinone + NADPH + H+
2 9,10-phenanthrenesemiquinone + NADP+
2 9,10-phenanthrenequinone + NADPH + H+
? + NADP+
-
70% of the activity with 9,10-phenanthrenequinone
-
-
?
2 decyl-plastoquinone + NADPH + H+
2 decyl-plastosemiquinone + NADP+
-
production of semiquinone by univalent catalysts is detectable by the reduction of ferricytochrome c by the semiquinone to ferrocytochrome c
-
-
?
2-hexenal + NADPH
hexanal + NADP+
-
-
-
-
?
2-nonenal + NADPH
nonanal + NADP+
-
-
-
-
?
2-pentenal + NADPH
pentanal + NADP+
-
-
-
-
?
3-buten-2-one + NADPH
2-butanone + NADP+
-
-
-
-
?
3-nonen-2-one + NADPH
2-nonanone + NADP+
-
-
-
-
?
3-penten-2-one + NADPH
2-pentanone + NADP+
-
-
-
-
?
4-hydroxy-2-hexenal + NADPH
4-hydroxy-hexanal + NADP+
-
-
-
-
?
4-hydroxy-2-nonenal + NADPH
4-hydroxy-nonanal + NADP+
-
-
-
-
?
5-hydroxy-1,4-naphthoquinone + NADPH
5-hydroxy-1,4-naphthoquinol + NADP+
5-hydroxy-1,4-naphthoquinone + NADPH + H+
5-hydroxy-1,4-naphthosemiquinone + NADP+
-
i.e. juglone. Production of semiquinone by univalent catalysts is detectable by the reduction of ferricytochrome c by the semiquinone to ferrocytochrome c
-
-
?
5-hydroxy-1,4-naphthoquinone + NADPH + H+
?
-
i.e. juglone
-
-
?
5-hydroxy-2-methyl-1,4-naphthoquinone + NADPH
5-hydroxy-2-methyl-1,4-naphthoquinol + NADP+
-
i.e. plumbagin, 0.9% of the activity with 1,2-naphthoquinone
-
-
-
5-hydroxy-2-methyl-1,4-naphthoquinone + NADPH + H+
5-hydroxy-2-methyl-1,4-naphthosemiquinone + NADP+
-
i.e. plumbagin. Production of semiquinone by univalent catalysts is detectable by the reduction of ferricytochrome c by the semiquinone to ferrocytochrome c
-
-
?
9,10-phenanthrenequinone + NADPH
9,10-phenanthrenequinol + NADP+
9,10-phenanthrenequinone + NADPH + H+
9,10-phenanthrenequinol + NADP+
Q7A492
one-electron reduction mechanism. Concomitantly with NADPH consumption, generation of superoxide is observed
-
-
?
9,10-phenanthrenequinone + NADPH + H+
9,10-phenanthrenesemiquinone + NADP+
-
production of semiquinone by univalent catalysts is detectable by the reduction of ferricytochrome c by the semiquinone to ferrocytochrome c
-
-
?
9,10-phenanthrenequinone + NADPH + H+
? + NADP+
-
the activity with 9,10-phenanthrenequinone and with 1,2-naphthoquinone is equal
-
-
?
dichlorophenolindophenol + NADPH + H+
reduced dichlorophenolindophenol + NADP+
ferricytochrome + NADPH + H+
ferrocytochrome + NADPH
-
-
-
-
?
menadione + NADPH + H+
menadiol + NADP+
methyl-1,4-benzoquinone + NADPH
methyl-1,4-benzoquinol + NADP+
-
20.6% of the activity with 1,2-naphthoquinone
-
-
-
NADPH + H+ + 2 2,5-dimethyl-4-benzoquinone
NADP+ + 2 2,5-dimethyl-4-benzosemiquinone
-
-
-
-
?
NADPH + H+ + 2 2-hydroxy-1,4-naphthoquinone
NADP+ + 2 2-hydroxy-1,4-naphthosemiquinone
-
-
-
-
?
NADPH + H+ + 2 anthraquinone-2-sulfonate
NADP+ + ?
-
-
-
-
?
NADPH + H+ + 2 coenzyme Q10
NADP+ + ?
-
-
-
-
?
NADPH + H+ + 2 dibromothymoquinone
NADP+ + 2 dibromothymosemiquinone
-
-
-
-
?
NADPH + H+ + 2 duroquinone
NADP+ + 2 durosemiquinone
-
-
-
-
?
NADPH + H+ + 2 menadione
NADP+ + ?
-
-
-
-
?
NADPH + H+ + 2 quinone
NADP+ + 2 semiquinone
NADPH + H+ + komaroviquinone
NADP+ + ?
-
reduction of komaroviquinone to its semiquinone radical. Antichagasic activity of komaroviquinone is due to generation of reactive oxygen species catalyzed by Trypanosoma cruzi old yellow enzyme
-
-
?
NADPH + H+ + menadione
NADP+ + ?
-
-
-
-
?
NADPH + H+ + nifurtimox
NADP+ + ?
-
-
-
-
?
NADPH + H+ + oxidized 2,6-dichlorophenolindophenol
NADP+ + reduced 2,6-dichlorophenolindophenol
propenal + NADPH
propanal + NADP+
-
-
-
-
?
additional information
?
-
1,2-naphthoquinone + NADPH

1,2-naphthoquinol + NADP+
-
-
-
-
-
1,2-naphthoquinone + NADPH
1,2-naphthoquinol + NADP+
-
-
-
-
-
1,4-benzoquinone + NADPH

1,4-benzoquinol + NADP+
-
-
-
-
-
1,4-benzoquinone + NADPH
1,4-benzoquinol + NADP+
-
15.3% of the activity with 1,2-naphthoquinone
-
-
-
1,4-naphthoquinone + NADPH

1,4-naphthoquinol + NADP+
-
-
-
-
-
1,4-naphthoquinone + NADPH
1,4-naphthoquinol + NADP+
-
-
-
-
-
1,4-naphthoquinone + NADPH
1,4-naphthoquinol + NADP+
-
2.6% of the activity with 1,2-naphthoquinone
-
-
-
2 9,10-phenanthrenequinone + NADPH + H+

2 9,10-phenanthrenesemiquinone + NADP+
-
production of semiquinone by univalent catalysts is detectable by the reduction of ferricytochrome c by the semiquinone to ferrocytochrome c
-
-
?
2 9,10-phenanthrenequinone + NADPH + H+
2 9,10-phenanthrenesemiquinone + NADP+
-
very strong reduction activity towards large substrates such as 9,10-phenanthrenequinone. The zeta-crystallin-like quinone oxidoreductase catalyzes one-electron reduction of certain quinones to generate semiquinone
-
-
?
5-hydroxy-1,4-naphthoquinone + NADPH

5-hydroxy-1,4-naphthoquinol + NADP+
-
-
-
-
-
5-hydroxy-1,4-naphthoquinone + NADPH
5-hydroxy-1,4-naphthoquinol + NADP+
-
i.e. juglone, 12.5% of the activity with 1,2-naphthoquinone
-
-
-
9,10-phenanthrenequinone + NADPH

9,10-phenanthrenequinol + NADP+
-
-
-
-
-
9,10-phenanthrenequinone + NADPH
9,10-phenanthrenequinol + NADP+
-
best substrate
-
-
-
9,10-phenanthrenequinone + NADPH
9,10-phenanthrenequinol + NADP+
-
-
-
-
-
9,10-phenanthrenequinone + NADPH
9,10-phenanthrenequinol + NADP+
-
50% of the activity with 1,2-naphthoquinone
-
-
-
dichlorophenolindophenol + NADPH + H+

reduced dichlorophenolindophenol + NADP+
-
-
-
-
?
dichlorophenolindophenol + NADPH + H+
reduced dichlorophenolindophenol + NADP+
-
production of semiquinone by univalent catalysts is detectable by the reduction of ferricytochrome c by the semiquinone to ferrocytochrome c
-
-
?
menadione + NADPH + H+

menadiol + NADP+
-
-
under aerobic conditions, menadiol is readily oxidized to menadione by two 1-electron steps producing the semiquinone and the parent quinone with concomitant production of superoxide anion, which leads to generation of hydroxyl radicals
-
?
menadione + NADPH + H+
menadiol + NADP+
Q7A492
-
-
-
?
NADPH + H+ + 2 quinone

NADP+ + 2 semiquinone
-
-
-
-
?
NADPH + H+ + 2 quinone
NADP+ + 2 semiquinone
-
the catalytic cycle of ArsH consists of the acceptance of two electrons from NADPH to reduce the flavin cofactor (reductive half-reaction) and the transfer of these electrons to an acceptor (oxidative half-reaction)
-
-
?
NADPH + H+ + oxidized 2,6-dichlorophenolindophenol

NADP+ + reduced 2,6-dichlorophenolindophenol
-
-
-
-
-
NADPH + H+ + oxidized 2,6-dichlorophenolindophenol
NADP+ + reduced 2,6-dichlorophenolindophenol
-
-
-
-
-
NADPH + H+ + oxidized 2,6-dichlorophenolindophenol
NADP+ + reduced 2,6-dichlorophenolindophenol
-
3.8% of the activity with 1,2-naphthoquinone
-
-
-
additional information

?
-
-
no activity with: phylloquinone (vitamin K1), menaquinone (vitamin K2), menadione (vitamin K3) and ferricyanide. Preference for o-quinones over p-quinones, and the inability to recognize menadione and ferricyanide as substrates, clearly distinguishe P1-ZCr and guinea-pig ZCr from the flavin-containing NAD(P)H-quinone oxidoreductases in plants and animals. P1-ZCr also catalyzed the divalent reduction of diamide to 1,2-bis(N,N-dimethylcarbamoyl)hydrazine, with a kcat comparable with that for quinones. Two other azodicarbonyl compounds also served as substrates of P1-ZCr. Guinea-pig ZCr, however, did not catalyze the azodicarbonyl reduction. Hence, plant ZCr is distinct from mammalian ZCr, and can be referred to as NADPH:azodicarbonyl/quinone reductase. The quinone-reducing reaction is accompanied by radical chain reactions to produce superoxide radicals, while the azodicarbonyl reducing reaction is not
-
-
-
additional information
?
-
-
no activity with menadione and 9,10-anthraquinone
-
-
-
additional information
?
-
-
inactive with: menadione, ubiquinone, 9,10-anthraquinone, vitamin K1, vitamin K2
-
-
-
additional information
?
-
-
although in the lens the enzyme is considered to be a crystallin, or lens structural protein, because of its high abundance its enzymatic activity and expression at catalytic levels in other tissues of various species suggest that it has a fundamental physiological role outside the lens, perhaps in the detoxification of xenobiotics
-
-
-
additional information
?
-
-
no activity with: phylloquinone (vitamin K1), menaquinone (vitamin K2), menadione (vitamin K3), ferricytochrome and ferricyanide. Preference for o-quinones over p-quinones, and the inability to recognize menadione and ferricyanide as substrates, clearly distinguishe Arabidopsis thaliana P1-ZCr and guinea-pig ZCr from the flavin-containing NAD(P)H-quinone oxidoreductases in plants and animals
-
-
-
additional information
?
-
-
although in the lens the enzyme is considered to be a crystallin, or lens structural protein, because of its high abundance its enzymatic activity and expression at catalytic levels in other tissues of various species suggest that it has a fundamental physiological role outside the lens, perhaps in the detoxification of xenobiotics
-
-
-
additional information
?
-
-
the human and yeast enzymes specifically bind to adenine-uracil rich elements (ARE) in RNA, indicating that both enzymes are ARE-binding proteins and that this property has been conserved in zeta-crystallins throughout evolution. This supports a role for zeta-crystallins as trans-acting factors that could regulate the turnover of certain mRNAs
-
-
-
additional information
?
-
-
enzyme reduces ortho-quinones in the presence of NADPH but is not active with 2-alkenals
-
-
-
additional information
?
-
-
the human and yeast enzymes specifically bind to adenine-uracil rich elements (ARE) in RNA, indicating that both enzymes are ARE-binding proteins and that this property has been conserved in zeta-crystallins throughout evolution. This supports a role for zeta-crystallins as trans-acting factors that could regulate the turnover of certain mRNAs
-
-
-
additional information
?
-
-
enzyme reduces ortho-quinones in the presence of NADPH but is not active with 2-alkenals
-
-
-
additional information
?
-
-
although the enzyme is able to stabilize the anionic semiquinone form of the FMN, reduction of quinones involves the hydroquinone form of the flavin cofactor, and the enzymatic reaction occurs through a ping pong-type mechanism. ArsH is able to catalyze one-electron reactions (oxygen and cytocrome c reduction), involving the FMN semiquinone form, but with lower efficiency
-
-
-
additional information
?
-
QR1 catalyzes the univalent reduction of quinones to semiquinone radicals
-
-
-
additional information
?
-
-
QR1 catalyzes the univalent reduction of quinones to semiquinone radicals
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
2,3-Dimercaptopropanol
-
-
2,5-Dichloro-3,6-dihydroxy-1,4-benzoquinone
-
i.e. chloranilic acid, noncompetitive with respect to both NADPH and 9,10-phenanthrenequinone
4-chloromercuribenzoate
-
both NADPH and NADP1 suppress the inhibition, but NADH does not
4-Hydroxycoumarin
-
reversible time-independent inhibition. Only dicoumarol, 4-hydroxycoumarin and warfarin inhibit in micromolar ranges. 7-Hydroxy-4-methylcoumarin is ineffective. Competitive inhibition with respect to 2,6-dichlorophenolindophenol, uncompetitive with respect to NADPH. Phenolic hydroxyl group at the C-4 position in the coumarin skeleton is important for the maximal inhibition. Sequence of potency for the inhibitors in descending order: dicoumarol, 4-hydroxycoumarin, warfarin, coumarin
5,5'-dithiobis(2-nitrobenzoate)
ADP
-
10% inhibition at 0.2 mM
coumarin
-
reversible time-independent inhibition. Only dicoumarol, 4-hydroxycoumarin and warfarin inhibit in micromolar ranges. 7-Hydroxy-4-methylcoumarin is ineffective. Competitive inhibition with respect to 2,6-dichlorophenolindophenol, uncompetitive with respect to NADPH. Phenolic hydroxyl group at the C-4 position in the coumarin skeleton is important for the maximal inhibition. Sequence of potency for the inhibitors in descending order: dicoumarol, 4-hydroxycoumarin, warfarin, coumarin
Cu2+
-
25% inhibition at 1 mM
FAD
-
60% inhibition at 0.2 mM
FMN
-
40% inhibition at 0.2 mM
N-ethylmaleimide
-
both NADPH and NADP1 suppress the inhibition, but NADH does not
NAD+
-
5% inhibition at 0.2 mM
p-Chloromercuriphenylsulfonate
-
-
pyridoxal-5'-phosphate
-
inactivation follows pseudo-first-order kinetics. NADPH protects against inactivation, 9,10-phenanthrenequinone does not protect. Inhibition is uncompetitive with NADPH and non-competitive with respect to 9,10-phenanthrenequinone
Zn2+
-
25% inhibition at 1 mM
5,5'-dithiobis(2-nitrobenzoate)

-
inactivation is caused by a modification of one Cys per subunit, reactivation by dithiothreitol or KCN. NADPH partially protects from inactivation, 9,10-phenanthrenequinone enhances the modification
5,5'-dithiobis(2-nitrobenzoate)
-
-
5,5'-dithiobis(2-nitrobenzoate)
-
-
Cibacron blue 3GA

-
inhibits the reaction with NADPH and 9,10-phenanthrenequinone. Linear mixed type inhibition with respect to NADPH and noncompetitive with respect to 9,10-phenanthrenequinone
dicoumarol

-
mixed-type inhibition against NADPH
dicoumarol
-
competitive with respect to 2,6-dichlorophenol-indophenol, uncompetitive with respect to NADPH
dicoumarol
-
reversible time-independent inhibition. Only dicoumarol, 4-hydroxycoumarin and warfarin inhibit in micromolar ranges. 7-Hydroxy-4-methylcoumarin is ineffective. Competitive inhibition with respect to 2,6-dichlorophenolindophenol, uncompetitive with respect to NADPH. Phenolic hydroxyl group at the C-4 position in the coumarin skeleton is important for the maximal inhibition.Sequence of potency for the inhibitors in descending order: dicoumarol, 4-hydroxycoumarin, warfarin, coumarin
dicoumarol
-
presence of dicoumarol decreases the production of hydroxyl radical and attenuates DNA strand-breaks in MCF-7 cells treated with menadione
dithiothreitol

-
inhibition is completely prevented by preincubation with 9,10-phenanthrenequinone but not by NADPH
dithiothreitol
-
strong competitive inhibition with respect to 9,10-phenanthrenequinone
NADP+

-
mixed-type inhibition with respect to NADPH, competitive with respect to 9,10-phenanthrenequinone
NADP+
-
can act as a competitive inhibitor for NADPH binding at the active site of an enzyme
NEM

-
-
Nitrofurantoin

-
uncompetitive against NADPH
warfarin

-
reversible time-independent inhibition. Only dicoumarol, 4-hydroxycoumarin and warfarin inhibit in micromolar ranges. 7-Hydroxy-4-methylcoumarin is ineffective. Competitive inhibition with respect to 2,6-dichlorophenolindophenol, uncompetitive with respect to NADPH. Phenolic hydroxyl group at the C-4 position in the coumarin skeleton is important for the maximal inhibition. Sequence of potency for the inhibitors in descending order: dicoumarol, 4-hydroxycoumarin, warfarin, coumarin
additional information

-
inhibition studies suggest that an essential disulfide-bridge is present at the binding site of zeta-crystallin
-
additional information
-
the results of the inhibition studies suggest that an essential Lys is located in the vicinity of the NADPH binding site
-
additional information
-
no inactivation by 0.5 mM iodoacetate
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Acidosis
Role of deadenylation and AUF1 binding in the pH-responsive stabilization of glutaminase mRNA.
Acidosis
Zeta-crystallin mediates the acid pH-induced increase of BSC1 cotransporter mRNA stability.
Acidosis
Zeta-crystallin: a tale of two cells.
Carcinogenesis
DT-diaphorase: possible roles in cancer chemotherapy and carcinogenesis.
Carcinoma, Hepatocellular
Direct determination of functional activity of cytochrome P-4501A1 and NADPH DT-diaphorase in hepatoma cell lines using noninvasive scanning laser cytometry.
Carcinoma, Hepatocellular
Induction of NADPH:quinone oxidoreductase in murine hepatoma cells by methylsulfinyl isothiocyanates: methyl chain length-activity study.
Carcinoma, Hepatocellular
The p53-inducible gene 3 involved in flavonoid-induced cytotoxicity through the reactive oxygen species-mediated mitochondrial apoptotic pathway in human hepatoma cells.
Cataract
A guinea-pig hereditary cataract contains a splice-site deletion in a crystallin gene.
Cataract
Assignment of the zeta-crystallin gene (CRYZ) to human chromosome 1p22-p31 and identification of restriction fragment length polymorphisms.
Cataract
Association of hereditary cataracts in strain 13/N guinea-pigs with mutation of the gene for zeta-crystallin.
Cataract
Expression of recombinant zeta-crystallin in Escherichia coli with the help of GroEL/ES and its purification.
Cataract
Identification and characterization of the enzymatic activity of zeta-crystallin from guinea pig lens. A novel NADPH:quinone oxidoreductase.
Cataract
Mutant zeta-crystallin from guinea-pig hereditary cataracts has altered structural and enzymatic properties.
Cataract
On the nature of hereditary cataract in strain 13/N guinea pigs.
Cataract
The transcripts of zeta-crystallin, a lens protein related to the alcohol dehydrogenase family, are altered in a guinea-pig hereditary cataract.
Cataract
Zeta-crystallin catalyzes the reductive activation of 2,4,6-trinitrotoluene to generate reactive oxygen species: a proposed mechanism for the induction of cataracts.
Infection
Differential regulation of wheat quinone reductases in response to powdery mildew infection.
Lens Diseases
A guinea-pig hereditary cataract contains a splice-site deletion in a crystallin gene.
Leukemia
{zeta}-Crystallin is a bcl-2 mRNA binding protein involved in bcl-2 overexpression in T-cell acute lymphocytic leukemia.
Neoplasms
Cigarette smoking is a determinant of DT-diaphorase gene expression in human non-small cell lung carcinoma.
Neoplasms
Differential induction of Cyp1a1, Cyp1b1, Ahd4, and Nmo1 in murine skin tumors and adjacent normal epidermis by ligands of the aryl hydrocarbon receptor.
Neoplasms
DT-diaphorase: possible roles in cancer chemotherapy and carcinogenesis.
Neoplasms
Fisetin induces transcription of NADPH:quinone oxidoreductase gene through an antioxidant responsive element-involved activation.
Neoplasms
Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues.
Neoplasms
Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachone.
Pancreatic Neoplasms
Dicumarol inhibition of NADPH:quinone oxidoreductase induces growth inhibition of pancreatic cancer via a superoxide-mediated mechanism.
Papilloma
Differential induction of Cyp1a1, Cyp1b1, Ahd4, and Nmo1 in murine skin tumors and adjacent normal epidermis by ligands of the aryl hydrocarbon receptor.
Paralysis
The murine aromatic hydrocarbon responsiveness locus: a comparison of receptor levels and several inducible enzyme activities among recombinant inbred lines.
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
{zeta}-Crystallin is a bcl-2 mRNA binding protein involved in bcl-2 overexpression in T-cell acute lymphocytic leukemia.
Sarcoma
Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachone.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Rao, P.V.; Krishna, C.M.; Zigler, J.S.
Identification and characterization of the enzymatic activity of zeta-Crystallin from guinea pig lens
J. Biol. Chem.
267
96-102
1992
Cavia porcellus
brenda
Duhaiman, A.S.; Rabbani, N.
Involvement of a disulfide bridge in catalytic activity of camel lens zeta-crystallin
Biochem. Biophys. Res. Commun.
221
229-233
1996
Camelus dromedarius
brenda
Duhaiman, A.S.; Rabbani, N.; AlJafari, A.A.; Alhomida, A.S.
Purification and characterization of zeta-crystallin from the camel lens
Biochem. Biophys. Res. Commun.
215
632-640
1995
Camelus dromedarius
brenda
Duhaiman, A.S.
Inhibition of camel lens zeta-crystallin/NADPH:quinone oxidoreductase activity by cibacron blue
J. Enzyme Inhib.
10
263-269
1996
Camelus dromedarius
brenda
Duhaiman, A.S.
Camel lens zeta-crystallin kinetics and its inhibition by dicoumarol
Biochem. Mol. Biol. Int.
38
251-258
1996
Camelus dromedarius
brenda
Abdulaziz, A.A A.; Riskuwa, A.S.; Duhaiman, A.S.
Inhibition of camel lens zeta-crystallin/NADPH:quinone oxidoreductase activity by chloranilic acid
Biochem. Mol. Biol. Int.
41
415-421
1997
Camelus dromedarius
brenda
Rao, P.V.; Zigler, J.S.
Purification and characterization of zeta-crystallin/quinone reductase from guinea pig liver
Biochim. Biophys. Acta
1117
315-320
1992
Cavia porcellus, Homo sapiens
brenda
Rabbani, N.; Duhaiman, A.S.
Inhibition of camel lens zeta-crystallin/NADPH:quinone oxidoreductase by pyridoxal-5'-phosphate
Biochim. Biophys. Acta
1388
175-180
1998
Camelus dromedarius
brenda
Duhaiman, A.S.
Inhibition of zeta-crystallin by coumarins: a structure-activity study
J. Protein Chem.
15
261-264
1996
Camelus dromedarius
brenda
Duhaiman, A.S.
Kinetic properties of camel lens zeta-crystallin
Int. J. Biochem. Cell Biol.
28
1163-1168
1996
Camelus dromedarius
brenda
Rao, P.V.; Gonzalez, P.; Persson, B.; Jornvall, H.; Garland, D.; Zigler, J.S.
Guinea pig and bovine zeta-crystallins have distinct functional characteristics highlighting replacements in otherwise similar structures
Biochemistry
36
5353-5362
1997
Bos taurus, Cavia porcellus
brenda
Shimomura, Y.; Kakuta, Y.; Fukuyama, K.
Crystal structures of the quinone oxidoreductase from Thermus thermophilus HB8 and its complex with NADPH: Implication for NADPH and substrate recognition
J. Bacteriol.
185
4211-4218
2003
Thermus thermophilus (Q8L3C8)
brenda
Uchiyama, N.; Kabututu, Z.; Kubata, B.K.; Kiuchi, F.; Ito, M.; Nakajima-Shimada, J.; Aoki, T.; Ohkubo, K.; Fukuzumi, S.; Martin, S.K.; Honda, G.; Urade, Y.
Antichagasic activity of komaroviquinone is due to generation of reactive oxygen species catalyzed by Trypanosoma cruzi old yellow enzyme
Antimicrob. Agents Chemother.
49
5123-5126
2005
Trypanosoma cruzi
brenda
Greenshields, D.L.; Liu, G.; Selvaraj, G.; Wei, Y.
Differential regulation of wheat quinone reductases in response to powdery mildew infection
Planta
222
867-875
2005
Triticum monococcum (Q56D13), Triticum monococcum
brenda
Pan, X.; Zhang, H.; Gao, Y.; Li, M.; Chang, W.
Crystal structures of Pseudomonas syringae pv. tomato DC3000 quinone oxidoreductase and its complex with NADPH.
Biochem. Biophys. Res. Commun.
390
597-602
2009
Pseudomonas syringae
brenda
Fernandez, M.R.; Porte, S.; Crosas, E.; Barbera, N.; Farres, J.; Biosca, J.A.; Pares, X.
Human and yeast zeta-crystallins bind AU-rich elements in RNA
Cell. Mol. Life Sci.
64
1419-1427
2007
Homo sapiens, Saccharomyces cerevisiae
brenda
Porte, S.; Crosas, E.; Yakovtseva, E.; Biosca, J.A.; Farres, J.; Fernandez, M.R.; Pares, X.
MDR quinone oxidoreductases: the human and yeast zeta-crystallins
Chem. Biol. Interact.
178
288-294
2009
Homo sapiens, Homo sapiens (Q08257), Saccharomyces cerevisiae (P38230), Saccharomyces cerevisiae
brenda
Mano, J.; Babiychuk, E.; Belles-Boix, E.; Hiratake, J.; Kimura, A.; Inze, D.; Kushnir, S.; Asada, K.
A novel NADPH:diamide oxidoreductase activity in Arabidopsis thaliana P1 zeta-crystallin
Eur. J. Biochem.
267
3661-3671
2000
Arabidopsis thaliana, Cavia porcellus
brenda
Huang, Q.L.; Du, X.Y.; Stone, S.H.; Amsbaugh, D.F.; Datiles, M.; Hu, T.S.; Zigler, J.S.
Association of hereditary cataracts in strain 13/N guinea-pigs with mutation of the gene for zeta-crystallin
Exp. Eye Res.
50
317-325
1990
Cavia porcellus 13/N, Cavia porcellus
brenda
Simpanya, M.F.; Leverenz, V.R.; Giblin, F.J.
Expression and purification of his-tagged recombinant mouse zeta-crystallin
Protein Expr. Purif.
69
147-152
2010
Mus musculus
brenda
Nutter, L.M.; Ngo, E.O.; Fisher, G.R.; Gutierrez, P.L.
DNA strand scission and free radical production in menadione-treated cells. Correlation with cytotoxicity and role of NADPH quinone acceptor oxidoreductase
J. Biol. Chem.
267
2474-2479
1992
Homo sapiens
brenda
Maruyama, A.; Kumagai, Y.; Morikawa, K.; Taguchi, K.; Hayashi, H.; Ohta, T.
Oxidative-stress-inducible qorA encodes an NADPH-dependent quinone oxidoreductase catalysing a one-electron reduction in Staphylococcus aureus
Microbiology
149
389-398
2003
Staphylococcus aureus (Q7A492), Staphylococcus aureus
brenda
Hervas, M.; Lopez-Maury, L.; Leon, P.; Sanchez-Riego, A.M.; Florencio, F.J.; Navarro, J.A.
ArsH from the cyanobacterium Synechocystis sp. PCC 6803 is an efficient NADPH-dependent quinone reductase
Biochemistry
51
1178-1187
2012
Synechocystis sp.
brenda
Porte, S.; Moeini, A.; Reche, I.; Shafqat, N.; Oppermann, U.; Farres, J.; Pares, X.
Kinetic and structural evidence of the alkenal/one reductase specificity of human zeta-crystallin
Cell. Mol. Life Sci.
68
1065-1077
2011
Homo sapiens (Q08257)
brenda